BTAIVSRLMD• 28 Days (Normalized)
BTAI vs RLMD (BioXcel Therapeutics Inc. vs Relmada Therapeutics Inc.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
-95.71%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
RLMD Performance $4.52
-5.83%
Relmada Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin RLMD LEADS
-89.88%
RLMD outperforming by 89.88%
BTAIRLMD
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI RLMD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | BTAI Price | BTAI Gain (%) | RLMD Price | RLMD Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $0.05 | -95.71% | $4.52 | -5.83% | -89.88% |
| Sep 10, 2026 | $0.05 | -95.80% | $4.07 | -15.21% | -80.59% |
| Sep 09, 2026 | $0.05 | -96.05% | $4.09 | -14.79% | -81.26% |
| Sep 08, 2026 | $0.04 | -96.39% | $4.25 | -11.46% | -84.93% |
| Sep 04, 2026 | $0.07 | -93.79% | $4.43 | -7.71% | -86.08% |
| Sep 03, 2026 | $0.12 | -90.08% | $4.37 | -8.96% | -81.12% |
| Sep 02, 2026 | $0.11 | -91.01% | $4.54 | -5.42% | -85.59% |
| Sep 01, 2026 | $0.14 | -88.49% | $4.46 | -7.08% | -81.41% |
| Aug 31, 2026 | $0.16 | -86.30% | $4.36 | -9.17% | -77.13% |
| Aug 28, 2026 | $0.18 | -84.79% | $4.33 | -9.79% | -75.00% |
| Aug 27, 2026 | $0.72 | -39.58% | $4.52 | -5.83% | -33.75% |
| Aug 26, 2026 | $0.78 | -34.45% | $4.55 | -5.21% | -29.24% |
| Aug 25, 2026 | $0.74 | -37.65% | $4.59 | -4.38% | -33.27% |
| Aug 24, 2026 | $0.76 | -36.05% | $4.58 | -4.58% | -31.47% |
| Aug 21, 2026 | $0.80 | -32.44% | $4.63 | -3.54% | -28.90% |
Page 1 of 2